156 related articles for article (PubMed ID: 32731768)
1. Association of Rs231775 Genetic Variant of Cytotoxic T-lymphocyte Associated Protein 4 with Alopecia Areata Disease in Males: A Case-Control Study.
Ismail NA; Toraih EA; Ameen HM; Gomaa AHA; Marie REM
Immunol Invest; 2021 Nov; 50(8):977-986. PubMed ID: 32731768
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic T-lymphocyte antigen 4 (CTLA4) +49AG and CT60 gene polymorphisms in Alopecia Areata: a case-control association study in the Italian population.
Megiorni F; Mora B; Maxia C; Gerardi M; Pizzuti A; Rossi A
Arch Dermatol Res; 2013 Sep; 305(7):665-70. PubMed ID: 23567921
[TBL] [Abstract][Full Text] [Related]
3. CTLA4 +49AG (rs231775) and CT60 (rs3087243) gene variants are not associated with alopecia areata in a Mexican population from Monterrey Mexico.
Salinas-Santander MA; Cantu-Salinas CS; Ocampo-Candiani J; Suarez-Valencia VJ; Ramirez-Guerrero JG; Sanchez-Dominguez CN
An Bras Dermatol; 2020; 95(3):283-288. PubMed ID: 32278632
[TBL] [Abstract][Full Text] [Related]
4. Genetic variant association of PTPN22, CTLA4, IL2RA, as well as HLA frequencies in susceptibility to alopecia areata.
Moravvej H; Tabatabaei-Panah PS; Abgoon R; Khaksar L; Sokhandan M; Tarshaei S; Ghaderian SMH; Ludwig RJ; Akbarzadeh R
Immunol Invest; 2018 Oct; 47(7):666-679. PubMed ID: 29979892
[TBL] [Abstract][Full Text] [Related]
5. Association of Autoimmune Regulator Gene Rs2075876 Variant, but Not Gene Expression with Alopecia Areata in Males: A Case-control Study.
Toraih EA; Ameen HM; Hussein MH; Youssef Elabd AA; Mohamed AM; Abdel-Gawad AR; Fawzy MS
Immunol Invest; 2020 Feb; 49(1-2):146-165. PubMed ID: 31601134
[TBL] [Abstract][Full Text] [Related]
6. Impact of cytotoxic T-lymphocyte-associated protein 4 codon 17 variant and expression on vitiligo risk.
Gouda NS; Fawzy MS; Toraih EA
J Clin Lab Anal; 2021 Jun; 35(6):e23777. PubMed ID: 33932254
[TBL] [Abstract][Full Text] [Related]
7. Association of AIRE (rs2075876), but not CTLA4 (rs231775) polymorphisms with systemic lupus erythematosus.
Alghamdi SA; Kattan SW; Toraih EA; Alrowaili MG; Fawzy MS; Elshazli RM
Gene; 2021 Feb; 768():145270. PubMed ID: 33122082
[TBL] [Abstract][Full Text] [Related]
8. The association between Interleukin (IL)-4 gene intron 3 VNTR polymorphism and alopecia areata (AA) in Turkish population.
Kalkan G; Karakus N; Baş Y; Takçı Z; Ozuğuz P; Ateş O; Yigit S
Gene; 2013 Sep; 527(2):565-9. PubMed ID: 23831512
[TBL] [Abstract][Full Text] [Related]
9. Association of CTLA-4 gene polymorphisms and alopecia areata: a systematic review and meta-analysis.
Zhou B; Chen M; Shang S; Zhao J
Biomarkers; 2022 Jun; 27(4):338-348. PubMed ID: 35254172
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic T lymphocyte-associated antigen 4 rs231775 polymorphism and osteosarcoma.
Bilbao-Aldaiturriaga N; Patino-Garcia A; Martin-Guerrero I; Garcia-Orad A
Neoplasma; 2017; 64(2):299-304. PubMed ID: 28052683
[TBL] [Abstract][Full Text] [Related]
11. Effect of PTPN22, FAS/FASL, IL2RA and CTLA4 genetic polymorphisms on the risk of developing alopecia areata: A systematic review of the literature and meta-analysis.
Gil-Quiñones SR; Sepúlveda-Pachón IT; Sánchez Vanegas G; Gutierrez-Castañeda LD
PLoS One; 2021; 16(11):e0258499. PubMed ID: 34735462
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide association study in alopecia areata implicates both innate and adaptive immunity.
Petukhova L; Duvic M; Hordinsky M; Norris D; Price V; Shimomura Y; Kim H; Singh P; Lee A; Chen WV; Meyer KC; Paus R; Jahoda CA; Amos CI; Gregersen PK; Christiano AM
Nature; 2010 Jul; 466(7302):113-7. PubMed ID: 20596022
[TBL] [Abstract][Full Text] [Related]
13. CTLA-4 +49 G/A Polymorphism Confers Autoimmune Disease Risk: An Updated Meta-Analysis.
Wang K; Zhu Q; Lu Y; Lu H; Zhang F; Wang X; Fan Y
Genet Test Mol Biomarkers; 2017 Apr; 21(4):222-227. PubMed ID: 28384040
[TBL] [Abstract][Full Text] [Related]
14. The Association of CTLA-4 rs231775 and rs3087243 Polymorphisms with Latent Autoimmune Diabetes in Adults: A Meta-Analysis.
Pang H; Luo S; Huang G; Li X; Xie Z; Zhou Z
Biochem Genet; 2022 Aug; 60(4):1222-1235. PubMed ID: 34822071
[TBL] [Abstract][Full Text] [Related]
15. The CTLA4 +49 A/G (rs231775) polymorphism influences susceptibility to SLE in South Indian Tamils.
Devaraju P; Gulati R; Singh BK; Mithun CB; Negi VS
Tissue Antigens; 2014 Jun; 83(6):418-21. PubMed ID: 24758310
[TBL] [Abstract][Full Text] [Related]
16. Association of CTLA-4 (+49 A/G) polymorphism with susceptibility to autoimmune diseases: A meta-analysis with trial sequential analysis.
Yu L; Shao M; Zhou T; Xie H; Wang F; Kong J; Xu S; Shuai Z; Pan F
Int Immunopharmacol; 2021 Jul; 96():107617. PubMed ID: 33866246
[TBL] [Abstract][Full Text] [Related]
17. Adiponectin serum levels and ADIPOQ (rs2241766) polymorphism in alopecia areata Egyptian patients.
Farag AGA; Badr EA; Abd-Elaty BMG; Elnaidany NF; Ghanem MMM
An Bras Dermatol; 2024; 99(2):181-188. PubMed ID: 37985302
[TBL] [Abstract][Full Text] [Related]
18. Clinical and Genetic Aspects of Alopecia Areata: A Cutting Edge Review.
Ho CY; Wu CY; Chen JY; Wu CY
Genes (Basel); 2023 Jun; 14(7):. PubMed ID: 37510267
[TBL] [Abstract][Full Text] [Related]
19. Association between CTLA-4 rs231775 polymorphism and hepatocellular carcinoma susceptibility.
Liu Z; Song Z; Sun J; Sun F; Li C; Sun J; Xu L
Int J Clin Exp Pathol; 2015; 8(11):15118-22. PubMed ID: 26823853
[TBL] [Abstract][Full Text] [Related]
20. Hair Follicle-Related MicroRNA-34a Serum Expression and rs2666433A/G Variant in Patients with Alopecia: A Cross-Sectional Analysis.
Maher SA; Ismail NA; Toraih EA; Habib AH; Gouda NS; Gomaa AHA; Fawzy MS; Helal GM
Biomolecules; 2022 Apr; 12(5):. PubMed ID: 35625530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
